|
|
Volumn 5, Issue 4, 2003, Pages 287-293
|
|
Early rheumatoid arthritis: toward tailor-made therapy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
RHEUMATOID FACTOR;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DISEASE COURSE;
EARLY DIAGNOSIS;
HUMAN;
IMMUNOLOGY;
PREDICTION AND FORECASTING;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RHEUMATOID ARTHRITIS;
RISK FACTOR;
TREATMENT OUTCOME;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DISEASE PROGRESSION;
EARLY DIAGNOSIS;
HUMANS;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
RHEUMATOID FACTOR;
RISK FACTORS;
TREATMENT OUTCOME;
|
|
EID: 0642336152
PISSN: 15233774
EISSN: None
Source Type: Journal
DOI: 10.1007/s11926-003-0007-7 Document Type: Review |
|
Times cited : (5)
|
|
References (26)
|
